HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Assessment and management of acute severe asthma]

AbstractIn the management of acute severe asthma it is very important to start the treatment as soon as possible, by appropriate evaluation of the physical status and signs of airflow obstruction. We propose a guideline to be used by patients with asthma, emergency car crews, physicians and nurses to evaluate the severity and to choose the appropriate management of acute asthma, including intubation and mechanical ventilation, by the assessment of clinical features, as well as blood gas analysis and pulmonary function test. Several researchers have demonstrated that the additional administration of aminophylline to inhaled or subcutaneous beta 2-agonist bronchodilator during the first 4 hours of an attack provides no additional benefit compared to the administration of beta 2-agonist alone. In our retrospective study of 68 episodes of acute severe asthma in the last 5 years at our institute, however, the additional administration of aminophylline with beta 2-agonists was clearly shown to be effective with infrequent minor side effects.
AuthorsJ Kabe, K Kudo (Affiliation: Respiratory Division, National Medical Center Hospital, Tokyo, Japan.)
JournalNihon Kyōbu Shikkan Gakkai zasshi (Nihon Kyobu Shikkan Gakkai Zasshi) Vol. 30 Issue 9 Pg. 1643-9 (Sep 1992) ISSN: 0301-1542 [Print] JAPAN
PMID1360031 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Adrenergic beta-Agonists
  • Aminophylline
Topics
  • Acute Disease
  • Adrenergic beta-Agonists (therapeutic use)
  • Adult
  • Aminophylline (therapeutic use)
  • Blood Gas Analysis
  • Bronchoalveolar Lavage Fluid
  • Female
  • Humans
  • Male
  • Middle Aged
  • Peak Expiratory Flow Rate
  • Respiration, Artificial
  • Status Asthmaticus (diagnosis, physiopathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD